NEW YORK (GenomeWeb News) – Officials in Australia today launched a two-year, A$5.5 million (US$5.7 million) initiative to identify the common genetic mutations that cause melanoma.

The Australian Melanoma Genome Project brings together researchers from the Melanoma Institute Australia, the University of Sydney, Westmead Millennium Institute, Royal Prince Alfred Hospital and NSW Health Pathology, and the Queensland Institute of Medical Research to identify new methods of diagnosing and treating melanoma based on the genetic characteristics of individual melanomas.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.